Feed aggregator

Surreal! Salvador Dali's moustache remains intact, embalmer reveals after exhumation

Pharma news - July 21, 2017 - 8:12am

Salvador Dalí’s famous moustache remains in a perfect state, witnesses to the surrealist artist’s exhumation for DNA testing have revealed. Narcís Bardalet, Dalí’s embalmer, said that upon opening his crypt, the body was found to be exactly as it was when it was interred 28 years ago.  The handlebars of his moustache were still “marking (the time of) 10 past 10” as he wished, he said. Workers bring a casket to the Dali Theatre Museum  Credit: Manu Fernandez/AP “His moustache remains intact, marking 10 past 10, as he desired,” Mr Bardalet told local television. “It’s a miracle. Dalí will be with us for a long time”. The Spanish master was raised from his tomb in his hometown of Figueres late on Thursday night in a highly controversial operation to settle a paternity claim from a TV fortune teller that she is his secret lovechild. Pilar Abel poses for the media upon her arrival to the Toxicology National Institute to undergo a DNA test, in Madrid earlier this month Credit: EFE via EPA Pilar Abel, 61, also from Figueres, has for more than a decade been fighting to prove she is Dalí’s daughter, claiming to have learned from her mother and grandmother at the age of eight that she was the product of an affair with the married artist.  Despite being dismissed by many as a fraud, Ms Abel in June won a court order to exhume Dalí’s body, a Madrid judge ruling there was no other way to settle the claim. Salvador Dalí’s moustache was an iconic trademark of his appearance Credit: AFP/Getty The artist’s two tibias have been extracted as well as nails and teeth, and will now be taken to Madrid for testing before being replaced to preserve the integrity of the body, Lluís Peñuelas, secretary of the Gala-Salvador Dalí Foundation, said. Just 15 people were present at the exhumation  Credit: LLUIS GENE/AFP/Getty He stressed that the Foundation, which administers Dalí’s estate, regards the exhumation as “completely inappropriate” and Ms Abel’s claim as "baseless".  The exhumation was far from simple. Cranes were installed to lift the one and a half ton tombstone from Dalí’s crypt, which lies beneath the stage in the artist’s self-designed Theatre-Museum. Workers take scaffolding inside the Theatre-Museum Dali to be used in the exhumation  Credit: LLUIS GENE/AFP The operation took place under the cover of night, with media banned and tarpaulins placed over the top of the building to prevent drones spying from overhead.  Just 15 people were present and all phones and cameras were prohibited to prevent images leaking out.  The exhumation took place at the Theatre-Museum Dali in Figueras Credit: LLUIS GENE/AFP/Getty Marta Felip, the mayor of Figueres, said it was “grotesque” that the fortune teller’s claim had been taken so far. She said the results would be known in the first week of September, and said that if Ms Abel was found not to be the artist’s daughter, the Foundation and the local government would be seeking to recover their considerable costs. Tourists visit the tomb of Salvador Dali at the Theatre-Museum Dali following the exhumation  Credit: LLUIS GENE/AFP But if Ms Abel is proved right, she could be entitled to a 25 percent share of Dalí's considerable estate. That will open up another legal battle with the Foundation and the Spanish state, to which he left his works.  "The question of tracing any inheritance will be a difficult one," Michael Mylonas QC of London barristers' chambers Serjeants’ Inn told The Telegraph, suggesting that the Foundation "must be feeling some heat". Ms Abel told the Telegraph that she was unconcerned by the criticisms, and dismissed the Dalí Foundation’s questioning of the court order as “pathetic”. “I am very happy because at last it’s going to come to light, and this means a lot, it doesn’t matter to me what the Foundation says,” she said.  She insisted that she was not motivated by any potential inheritance but by a desire to know who she was. “It’s about my identity, and nothing else,” said Ms Abel, adding that the first thing she would do if the test came out positive was change her name. But then, she acknowledged, “probably I am going to ask for what is mine”. The fortune teller, who for eight years hosted a tarot card reading show on local television, claimed that the visionary Dalí was the source of her powers. “I have had this gift since I was little, and where else can it come from? It can’t be from anyone else but him.” Ms Abel said she believed the artist knew she was his child, relating an encounter told to her by her mother Antonia, who has given her blessing to the paternity suit. Her mother was pushing her in a pram when the pair ran into Dalí; he allegedly patted her head and remarked “So this is my daughter Pilar, eh?”. Ms Abel had crossed paths with him again as a teenager, and the pair had exchanged “looks that were more than looks”, she said. Shrugging off suggestions of an unseemly spectacle, the fortune teller said she was happy to have put Dalí back in the news. “It is what I wanted, to lift him up again. He deserves it. A great genius, a great person, and a great painter.”

Categories: Pharma News

Venezuela diplomat says he resigned to protest Maduro acts

Pharma news - July 21, 2017 - 8:03am

UNITED NATIONS (AP) — Venezuelan diplomat Isaias Medina said he resigned because of the systematic persecution of civilians, "state terrorism" and violations of the constitution by President Nicolas Maduro's government — and he said Maduro should resign too.

Categories: Pharma News

Syrian army and Hezbollah launch attack near Lebanese border

Pharma news - July 21, 2017 - 8:02am

BEIRUT (AP) — The Syrian army and members of Lebanon's militant Hezbollah group launched a major ground offensive on Friday aimed at ending the yearslong presence of hundreds of militants in a border area between the two countries.

Categories: Pharma News

5 Small-Cap Stocks with Big Dividends

Pharma news - July 21, 2017 - 8:00am

When most investors think of the best dividend stocks, they often think of Johnson & Johnson (ticker: JNJ) or Procter and Gamble Co. ( PG). Remember, small-cap dividend stocks come with more risk to cyclical trends in the economy or disruption to revenue. The best part for income investors, however, is that the reliable revenue stream from Extended Stay properties mean this $4 billion company can provide reliable dividends.

Categories: Pharma News

Samsung and Google are finally on the same side as Apple in a new battle

Pharma news - July 21, 2017 - 7:51am

It remains to be seen how Apple's legal battle with Qualcomm is going to play out, but from what we can tell so far, it seems as if the entire tech industry has already taken sides with Apple. If you recall, Apple earlier this year filed a $1 billion lawsuit against Qualcomm, alleging that the company employed anticompetitive business tactics as a means to extract incredibly high royalty payments from Apple for the LTE chips that go into the iPhone.

From Apple's vantage point, the royalty rates Qualcomm charges Apple aren't based on fair, reasonable and non-discriminatory (FRAND) terms, but is rather computed as a function of the iPhone's overall selling price. This approach, Tim Cook explained a few months back, is akin to a sofa manufacturer constantly changing the price of each sofa it sells based "on the price of the house it goes into."

Immediately after being slapped with the suit, Qualcomm, predictably, denied all wrongdoing and vowed to vigorously defend itself. A few months later, Qualcomm fired back with a legal suit of its own and asked the International Trade Commission (ITC) to issue a ban on all imports of iPhone and iPad models that use Qualcomm chips.

With that as a backdrop, a lobbying group called the Computer and Communications Industry Association (CCIA) -- a group whose members include tech heavyweights such as Microsoft, Amazon, Facebook, Samsung, Google, Intel and others -- filed a third-party brief yesterday asking the ITC to reject Qualcomm's proposed ITC ban. Incidentally, Apple is not a member of the CCIA.

A press release accompanying the legal filing reads in part:

CCIA told the ITC that Qualcomm’s request would harm consumers by enabling Qualcomm’s anti-competitive behavior.

CCIA has advocated on open competition issues for more than 40 years. Apple is not a member of this international tech trade association. The following can be attributed to CCIA President & CEO Ed Black:

“Qualcomm is already using its dominant position to pressure competitors and tax competing products. If the ITC were to grant this exclusion order, it would help Qualcomm use its monopoly power for further leverage against Apple, and allow them to drive up prices on consumer devices.

Incidentally, Qualcomm just a few days ago was hit with a countersuit from four of Apple's major iPhone manufacturers, a group that includes Hon Hai Precision Industry, Compal Electronics, Wistron Corp and Pegatron Corp.

While Qualcomm CEO Steve Mollenkopf recently said that the ongoing legal spat with Apple will likely be settled out of court, the growing number of companies joining forces against Qualcomm perhaps suggests that any forthcoming settlement -- should one happen -- will be heavily skewed in Apple's favor. In the interim, shares of Qualcomm are down nearly 20% since Apple first filed suit about seven months ago.

Categories: Pharma News

USS Fitzgerald crash that killed seven American sailors 'was navy's own fault'

Pharma news - July 21, 2017 - 7:38am

A deadly crash between a US warship and a Philippine cargo vessel is believed to have been the fault of the US navy, according to CNN citing preliminary investigations into the incident which claimed the lives of seven American sailors. The network said that two officials from the Department of Defence said that there were multiple errors by the crew of the USS Fitzgerald that led to the collision in June. The crash between the Fitzgerald, an Arleigh Burke-class destroyer, and the ACX Crystal on 17 June claimed the lives of seven US sailors.

Categories: Pharma News

WHO sees high risk from Kenya cholera outbreak

Reuters Health News - July 21, 2017 - 7:33am
GENEVA (Reuters) - An outbreak of cholera in Kenya poses a high risk to the region and a moderate threat globally, the World Health Organization said on Friday, after delegates at two international conferences were hit.
Categories: Consumer Health News

Here's how much money O.J. Simpson could have made while in prison

Pharma news - July 21, 2017 - 7:32am

O.J. Simpson was granted parole this week after being in prison for nearly nine years and, turns out, he's coming into some cash once he's released in as early as October.

Categories: Pharma News

Mercedes-Benz Builds 300,000th G-Class

Pharma news - July 21, 2017 - 7:28am

After 38 years in production, Mercedes' hand-built luxury SUV has just seen the 300,000th unit roll off the production line at the Magna Steyr facility in Graz, Austria, where it's been built throughout its entire lifespan. While some vehicles that have been in the market for several decades have sold tens of millions of units, there are other models with equally long and illustrious histories that are altogether more exclusive. One that certainly falls into that latter category is the iconic Mercedes-Benz Geländewagen, or G-Wagen as it's more commonly known.

Categories: Pharma News

Yemen cholera to spread with rains; Oxfam sees 600,000 cases

Reuters Health News - July 21, 2017 - 7:27am
GENEVA (Reuters) - Yemen's cholera outbreak is far from being controlled and may be further exacerbated by the rainy season, even if the rate of new cases appears to be slowing in some hotspots, the World Health Organisation said on Friday.
Categories: Consumer Health News

Pakistan's top court weighs dismissal of PM over corruption report

Pharma news - July 21, 2017 - 6:55am

By Drazen Jorgic ISLAMABAD (Reuters) - Pakistan's Supreme Court on Friday finished hearing arguments on a scathing corruption report into the family wealth of Prime Minister Nawaz Sharif, and will begin deliberating whether to disqualify the premier. The court is expected to make a decision in a week or two, with analysts split on whether it will dismiss Sharif outright or recommend a fresh investigation and corruption trial by the National Accountability Bureau (NAB). Few expect the judges to drop the case, since the Supreme Court appointed the investigatory panel that alleged the Sharif family's wealth was beyond its means.

Categories: Pharma News

EMA panel recommends against Nektar, Daiichi Sankyo's breast cancer drug

Reuters Health News - July 21, 2017 - 6:55am
(Reuters) - European regulators on Friday recommended against granting approval to a breast cancer drug being developed by Nektar Therapeutics and Daiichi Sankyo's German unit.
Categories: Consumer Health News

Janssen-Cilag's HIV drug gets EU regulatory panel's nod

Reuters Health News - July 21, 2017 - 6:46am
(Reuters) - A European regulatory panel recommended granting approval to a treatment for HIV infection developed by Janssen-Cilag International, a unit of U.S. drugmaker Johnson & Johnson.
Categories: Consumer Health News

Pfizer, Merck KGaA skin cancer drug gets EMA nod for approval

Reuters Health News - July 21, 2017 - 6:36am
(Reuters) - European regulators on Friday recommended approving Pfizer Inc and Merck KGaA's immuno-oncology drug Bavencio to treat a rare type of skin cancer called Merkel cell carcinoma.
Categories: Consumer Health News

EU medicines agency recommends approval of Novartis leukaemia drug Rydapt

Reuters Health News - July 21, 2017 - 6:35am
ZURICH (Reuters) - A European Medicines Agency (EMA) panel recommended on Friday approval of a new Novartis drug to be used against a tough-to-cure form of blood cancer as the Swiss drugmaker makes headway on refreshing its oncology portfolio.
Categories: Consumer Health News

Scaramucci Hints at How He'll Deal With Trump's Tweets

Pharma news - July 21, 2017 - 6:29am

Anthony Scaramucci, the new White House Communications Director, answers a question from NBC News' Hallie Jackson about getting the White House back on track.

Categories: Pharma News

Ina Garten's favorite kitchen tool costs less than $10

Pharma news - July 21, 2017 - 6:29am

If you've binge-watched a Saturday-morning marathon of Barefoot Contessa, chances are you're probably gawking at Ina Garten's magnificent kitchen in the Hamptons just as much as you are learning how to roast the perfect chicken.

Categories: Pharma News

Trump Issues Statement On Sean Spicer Resignation

Pharma news - July 21, 2017 - 6:25am

Deputy White House Press Secretary Sarah Huckabee Sanders reads a statement from President Trump change from Sean Spicer to Anthony Scaramucci.

Categories: Pharma News

Former DOJ spox: We 'need to expand our imagination about what [Trump] might do to stop' Mueller

Pharma news - July 21, 2017 - 6:23am

President Donald Trump has put his attorney general and the FBI's special counsel in his crosshairs in recent days.

Categories: Pharma News

Audi voluntarily recalls up to 850,000 diesel vehicles

Pharma news - July 21, 2017 - 6:08am

German luxury carmaker Audi, a Volkswagen subsidiary, issued a voluntary recall of up to 850,000 diesel vehicles Friday, saying it would help reduce engine emissions. "Audi aims to maintain the future viability of diesel engines for its customers and to make a contribution towards improving air quality," the Bavaria-based manufacturer said in a statement. Vehicles with affected engines would receive a free software upgrade that "will further improve their emissions in real driving conditions beyond the current legal requirements," Audi added.

Categories: Pharma News
Syndicate content